Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Bartoloni

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Clinical and Experimental Rheumatology|June 19, 2012
Primary Sjögren's syndrome as paraneoplastic disorder: a case reportE Bartoloni, A Alunno, R Gerli
Reumatismo|April 17, 2009
[Analysis of foot structural damage in rheumatoid arthritis: clinical evaluation by validated measures and serological correlations]D Biscontini, E Bartoloni Bocci, R Gerli
Clinical and Experimental Rheumatology|November 18, 2009
Successful treatment of refractory adult-onset Still's disease with anti-CD20 monoclonal antibodyE Bartoloni, A Alunno, F Luccioli, et al.
Clinical and Experimental Rheumatology|May 29, 2009
Crescentic glomerulonephritis and circulating antineutrophil cytoplasmic antibodies in scleroderma: a case report and review of the literatureE Bartoloni Bocci, A Giordano, F Luccioli, et al.
Reumatismo|September 18, 2023
Vasculitis associated with adenosine deaminase 2 deficiency: at the crossroads between Behçet's disease and autoinflammation. A viewpointA Colangelo, F Tromby, G Cafaro, et al.
Annals of the Rheumatic Diseases|April 15, 2008
Association of anti-cyclic citrullinated peptide antibodies with subclinical atherosclerosis in patients with rheumatoid arthritisR Gerli, E Bartoloni Bocci, Y Sherer, et al.
Rheumatology (Oxford, England)|October 18, 2006
Traditional cardiovascular risk factors in primary Sjögren's syndrome--role of dyslipidaemiaR Gerli, E Bartoloni Bocci, G Vaudo, et al.
Lupus|May 27, 2011
Increased levels of circulating DNA in patients with systemic autoimmune diseases: A possible marker of disease activity in Sjögren's syndromeE Bartoloni, V Ludovini, A Alunno, et al.
Journal of Internal Medicine|October 22, 2019
Interplay of anti-SSA/SSB status and hypertension in determining cardiovascular risk in primary Sjögren's syndromeE Bartoloni, C Baldini, S De Vita, et al.
Reumatismo|September 22, 2017
The clinical spectrum of primary Sjögren's syndrome: beyond exocrine glandsM C Leone, A Alunno, G Cafaro, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Clinical and Experimental Rheumatology|June 19, 2012
Primary Sjögren's syndrome as paraneoplastic disorder: a case reportE Bartoloni, A Alunno, R Gerli
Reumatismo|April 17, 2009
[Analysis of foot structural damage in rheumatoid arthritis: clinical evaluation by validated measures and serological correlations]D Biscontini, E Bartoloni Bocci, R Gerli
Clinical and Experimental Rheumatology|November 18, 2009
Successful treatment of refractory adult-onset Still's disease with anti-CD20 monoclonal antibodyE Bartoloni, A Alunno, F Luccioli, et al.
Clinical and Experimental Rheumatology|May 29, 2009
Crescentic glomerulonephritis and circulating antineutrophil cytoplasmic antibodies in scleroderma: a case report and review of the literatureE Bartoloni Bocci, A Giordano, F Luccioli, et al.
Reumatismo|September 18, 2023
Vasculitis associated with adenosine deaminase 2 deficiency: at the crossroads between Behçet's disease and autoinflammation. A viewpointA Colangelo, F Tromby, G Cafaro, et al.
Annals of the Rheumatic Diseases|April 15, 2008
Association of anti-cyclic citrullinated peptide antibodies with subclinical atherosclerosis in patients with rheumatoid arthritisR Gerli, E Bartoloni Bocci, Y Sherer, et al.
Rheumatology (Oxford, England)|October 18, 2006
Traditional cardiovascular risk factors in primary Sjögren's syndrome--role of dyslipidaemiaR Gerli, E Bartoloni Bocci, G Vaudo, et al.
Lupus|May 27, 2011
Increased levels of circulating DNA in patients with systemic autoimmune diseases: A possible marker of disease activity in Sjögren's syndromeE Bartoloni, V Ludovini, A Alunno, et al.
Journal of Internal Medicine|October 22, 2019
Interplay of anti-SSA/SSB status and hypertension in determining cardiovascular risk in primary Sjögren's syndromeE Bartoloni, C Baldini, S De Vita, et al.
Reumatismo|September 22, 2017
The clinical spectrum of primary Sjögren's syndrome: beyond exocrine glandsM C Leone, A Alunno, G Cafaro, et al.
Pageof 3